Literature DB >> 27997139

Isotope Dilution nanoLC/ESI+-HRMS3 Quantitation of Urinary N7-(1-Hydroxy-3-buten-2-yl) Guanine Adducts in Humans and Their Use as Biomarkers of Exposure to 1,3-Butadiene.

Dewakar Sangaraju, Emily J Boldry, Yesha M Patel1, Vernon Walker2, Irina Stepanov, Daniel Stram1, Dorothy Hatsukami, Natalia Tretyakova.   

Abstract

1,3-Butadiene (BD) is an important industrial and environmental chemical classified as a known human carcinogen. Occupational exposure to BD in the polymer and monomer industries is associated with an increased incidence of lymphoma. BD is present in automobile exhaust, cigarette smoke, and forest fires, raising concern about potential exposure of the general population to this carcinogen. Following inhalation exposure, BD is bioactivated to 3,4-epoxy-1-butene (EB). If not detoxified, EB is capable of modifying guanine and adenine bases of DNA to form nucleobase adducts, which interfere with accurate DNA replication and cause cancer-initiating mutations. We have developed a nanoLC/ESI+-HRMS3 methodology for N7-(1-hydroxy-3-buten-2-yl) guanine (EB-GII) adducts in human urine (limit of detection: 0.25 fmol/mL urine; limit of quantitation: 1.0 fmol/mL urine). This new method was successfully used to quantify EB-GII in urine of F344 rats treated with 0-200 ppm of BD, occupationally exposed workers, and smokers belonging to two different ethnic groups. EB-GII amounts increased in a dose-dependent manner in urine of laboratory rats exposed to 0, 62.5, or 200 ppm of BD. Urinary EB-GII levels were significantly increased in workers occupationally exposed to 0.1-2.2 ppm of BD (1.25 ± 0.51 pg/mg of creatinine) as compared to administrative controls exposed to <0.01 ppm of BD (0.22 ± 0.08 and pg/mg of creatinine) (p = 0.0024), validating the use of EB-GII as a biomarker of human exposure to BD. EB-GII was also detected in smokers' urine with European American smokers excreting significantly higher amounts of EB-GII than African American smokers (0.48 ± 0.09 vs 0.12 ± 0.02 pg/mg of creatinine, p = 3.1 × 10-7). Interestingly, small amounts of EB-GII were observed in animals and humans with no known exposure to BD, providing preliminary evidence for its endogenous formation. Urinary EB-GII adduct levels and urinary mercapturic acids of BD (MHBMA, DHBMA) were compared in a genotyped multiethnic smoker cohort.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27997139      PMCID: PMC5515386          DOI: 10.1021/acs.chemrestox.6b00407

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  51 in total

1.  1,3-Butadiene: Biomarkers and application to risk assessment.

Authors:  James A Swenberg; Narisa K Bordeerat; Gunnar Boysen; Sujey Carro; Nadia I Georgieva; Jun Nakamura; John M Troutman; Patricia B Upton; Richard J Albertini; Pamela M Vacek; Vernon E Walker; Radim J Sram; Melissa Goggin; Natalia Tretyakova
Journal:  Chem Biol Interact       Date:  2010-10-23       Impact factor: 5.192

2.  Puff-by-puff resolved characterisation of cigarette mainstream smoke by single photon ionisation (SPI)-time-of-flight mass spectrometry (TOFMS): comparison of the 2R4F research cigarette and pure Burley, Virginia, Oriental and Maryland tobacco cigarettes.

Authors:  Thomas Adam; Stefan Mitschke; Thorsten Streibel; Richard R Baker; Ralf Zimmermann
Journal:  Anal Chim Acta       Date:  2006-05-22       Impact factor: 6.558

Review 3.  Mass spectrometry of structurally modified DNA.

Authors:  Natalia Tretyakova; Peter W Villalta; Srikanth Kotapati
Journal:  Chem Rev       Date:  2013-02-26       Impact factor: 60.622

4.  Quantifying etheno-DNA adducts in human tissues, white blood cells, and urine by ultrasensitive (32)P-postlabeling and immunohistochemistry.

Authors:  Jagadeesan Nair; Urmila J Nair; Xin Sun; Ying Wang; Khelifa Arab; Helmut Bartsch
Journal:  Methods Mol Biol       Date:  2011

5.  Biomarkers for assessing occupational exposures to 1,3-butadiene.

Authors:  R J Albertini; R J Sram; P M Vacek; J Lynch; M Wright; J A Nicklas; P J Boogaard; R F Henderson; J A Swenberg; A D Tates; J B Ward
Journal:  Chem Biol Interact       Date:  2001-06-01       Impact factor: 5.192

6.  1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.

Authors:  I A Blair; T Oe; S Kambouris; A K Chaudhary
Journal:  Res Rep Health Eff Inst       Date:  2000-03

Review 7.  N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides.

Authors:  Gunnar Boysen; Nadia I Georgieva; Patricia B Upton; Vernon E Walker; James A Swenberg
Journal:  Chem Biol Interact       Date:  2006-11-07       Impact factor: 5.192

8.  Polycyclic aromatic hydrocarbon exposure, urinary mutagenicity, and DNA adducts in rubber manufacturing workers.

Authors:  Susan Peters; Glenn Talaska; Bo A G Jönsson; Hans Kromhout; Roel Vermeulen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-06       Impact factor: 4.254

9.  Formation and repair of tobacco carcinogen-derived bulky DNA adducts.

Authors:  Bo Hang
Journal:  J Nucleic Acids       Date:  2010-12-20

10.  Benzene Uptake and Glutathione S-transferase T1 Status as Determinants of S-Phenylmercapturic Acid in Cigarette Smokers in the Multiethnic Cohort.

Authors:  Christopher A Haiman; Yesha M Patel; Daniel O Stram; Steven G Carmella; Menglan Chen; Lynne R Wilkens; Loic Le Marchand; Stephen S Hecht
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

View more
  9 in total

Review 1.  Chemical Analysis of DNA Damage.

Authors:  Yang Yu; Pengcheng Wang; Yuxiang Cui; Yinsheng Wang
Journal:  Anal Chem       Date:  2017-11-07       Impact factor: 6.986

2.  Urinary N7-(1-hydroxy-3-buten-2-yl) guanine adducts in humans: temporal stability and association with smoking.

Authors:  Caitlin C Jokipii Krueger; Guru Madugundu; Amanda Degner; Yesha Patel; Daniel O Stram; Timothy R Church; Natalia Tretyakova
Journal:  Mutagenesis       Date:  2020-02-13       Impact factor: 3.000

3.  Interindividual Differences in DNA Adduct Formation and Detoxification of 1,3-Butadiene-Derived Epoxide in Human HapMap Cell Lines.

Authors:  Amanda Degner; Rashi Arora; Luke Erber; Christopher Chao; Lisa A Peterson; Natalia Y Tretyakova
Journal:  Chem Res Toxicol       Date:  2020-04-15       Impact factor: 3.739

4.  Intra- and Inter-Species Variability in Urinary N7-(1-Hydroxy-3-buten-2-yl)guanine Adducts Following Inhalation Exposure to 1,3-Butadiene.

Authors:  Luke Erber; Samantha Goodman; Fred A Wright; Weihsueh A Chiu; Natalia Y Tretyakova; Ivan Rusyn
Journal:  Chem Res Toxicol       Date:  2021-11-02       Impact factor: 3.739

Review 5.  1,3-Butadiene: a ubiquitous environmental mutagen and its associations with diseases.

Authors:  Wan-Qi Chen; Xin-Yu Zhang
Journal:  Genes Environ       Date:  2022-01-10

6.  Use of Biomarker Data and Relative Potencies of Mutagenic Metabolites to Support Derivation of Cancer Unit Risk Values for 1,3-Butadiene from Rodent Tumor Data.

Authors:  Christopher R Kirman; Sean M Hays
Journal:  Toxics       Date:  2022-07-15

7.  Applying Tobacco, Environmental, and Dietary-Related Biomarkers to Understand Cancer Etiology and Evaluate Prevention Strategies.

Authors:  Lisa A Peterson; Silvia Balbo; Naomi Fujioka; Dorothy K Hatsukami; Stephen S Hecht; Sharon E Murphy; Irina Stepanov; Natalia Y Tretyakova; Robert J Turesky; Peter W Villalta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-12       Impact factor: 4.254

8.  Effects of GSTT1 Genotype on the Detoxification of 1,3-Butadiene Derived Diepoxide and Formation of Promutagenic DNA-DNA Cross-Links in Human Hapmap Cell Lines.

Authors:  Gunnar Boysen; Rashi Arora; Amanda Degner; Karin R Vevang; Christopher Chao; Freddys Rodriguez; Scott J Walmsley; Luke Erber; Natalia Y Tretyakova; Lisa A Peterson
Journal:  Chem Res Toxicol       Date:  2020-12-31       Impact factor: 3.739

9.  Ethnic differences in excretion of butadiene-DNA adducts by current smokers.

Authors:  Caitlin C Jokipii Krueger; S Lani Park; Guru Madugundu; Yesha Patel; Loic Le Marchand; Daniel O Stram; Natalia Tretyakova
Journal:  Carcinogenesis       Date:  2021-05-28       Impact factor: 4.944

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.